Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratú G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J.

Ann Oncol. 2019 Aug 13. pii: mdz216. doi: 10.1093/annonc/mdz216. [Epub ahead of print] No abstract available.

PMID:
31406995
2.

Early Colorectal Cancers Provide New Evidence for a Lynch Syndrome-to-CMMRD Phenotypic Continuum.

Fernandez-Rozadilla C, Alvarez-Barona M, Schamschula E, Bodo S, Lopez-Novo A, Dacal A, Calviño-Costas C, Lancho A, Amigo J, Bello X, Cameselle-Teijeiro JM, Carracedo A, Colas C, Muleris M, Wimmer K, Ruiz-Ponte C.

Cancers (Basel). 2019 Jul 30;11(8). pii: E1081. doi: 10.3390/cancers11081081.

3.

Cribriform-morular variant of thyroid carcinoma.

Cameselle-Teijeiro JM, Sobrinho-Simões M.

Pathologica. 2019 Mar;111(1):1-3. doi: 10.32074/1591-951X-66-18. No abstract available.

PMID:
31217615
4.

Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors.

Sampedro-Núñez M, Serrano-Somavilla A, Adrados M, Cameselle-Teijeiro JM, Blanco-Carrera C, Cabezas-Agricola JM, Martínez-Hernández R, Martín-Pérez E, Muñoz de Nova JL, Díaz JÁ, García-Centeno R, Caneiro-Gómez J, Abdulkader I, González-Amaro R, Marazuela M.

Sci Rep. 2018 Dec 13;8(1):17812. doi: 10.1038/s41598-018-36129-1.

5.

Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway.

Cameselle-Teijeiro JM, Peteiro-González D, Caneiro-Gómez J, Sánchez-Ares M, Abdulkader I, Eloy C, Melo M, Amendoeira I, Soares P, Sobrinho-Simões M.

Mod Pathol. 2018 Aug;31(8):1168-1179. doi: 10.1038/s41379-018-0070-2. Epub 2018 May 21. Review.

6.

Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer.

Chorny JA, Orrego JJ, Cameselle-Teijeiro JM.

Endocrinol Diabetes Metab Case Rep. 2018 Apr 17;2018. pii: 18-0036. doi: 10.1530/EDM-18-0036. eCollection 2018.

7.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratù G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J.

Ann Oncol. 2018 Jun 1;29(6):1454-1460. doi: 10.1093/annonc/mdy123.

PMID:
29648575
8.

Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.

Cameselle-Teijeiro JM, Mato Mato JA, Fernández Calvo O, García Mata J.

Mol Diagn Ther. 2018 Apr;22(2):169-177. doi: 10.1007/s40291-018-0315-2. Review.

PMID:
29427124
9.

New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms.

Cameselle-Teijeiro JM, Sobrinho-Simões M.

Endocrinol Diabetes Nutr. 2018 Mar;65(3):133-135. doi: 10.1016/j.endinu.2017.11.012. Epub 2018 Feb 7. English, Spanish. No abstract available.

PMID:
29396216
10.

Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age.

Villar-Taibo R, Peteiro-González D, Cabezas-Agrícola JM, Aliyev E, Barreiro-Morandeira F, Ruiz-Ponte C, Cameselle-Teijeiro JM.

Oncol Lett. 2017 May;13(5):3501-3507. doi: 10.3892/ol.2017.5948. Epub 2017 Mar 29.

11.

Comments on «Incidental versus non-incidental thyroid carcinoma: Clinical presentation, surgical management and prognosis».

Ladra González MJ, Peteiro González D, Aliyev E, Barreiro Morandeira F, Cameselle-Teijeiro JM.

Endocrinol Diabetes Nutr. 2017 Apr;64(4):232-233. doi: 10.1016/j.endinu.2017.01.006. Epub 2017 Mar 15. English, Spanish. No abstract available.

PMID:
28417878
12.

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.

Melo M, Gaspar da Rocha A, Batista R, Vinagre J, Martins MJ, Costa G, Ribeiro C, Carrilho F, Leite V, Lobo C, Cameselle-Teijeiro JM, Cavadas B, Pereira L, Sobrinho-Simões M, Soares P.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1898-1907. doi: 10.1210/jc.2016-2785.

PMID:
28323937
13.

The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.

García M, Barrio R, García-Lavandeira M, Garcia-Rendueles AR, Escudero A, Díaz-Rodríguez E, Gorbenko Del Blanco D, Fernández A, de Rijke YB, Vallespín E, Nevado J, Lapunzina P, Matre V, Hinkle PM, Hokken-Koelega AC, de Miguel MP, Cameselle-Teijeiro JM, Nistal M, Alvarez CV, Moreno JC.

Sci Rep. 2017 Mar 6;7:42937. doi: 10.1038/srep42937.

14.

EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).

Oliveira G, Polónia A, Cameselle-Teijeiro JM, Leitão D, Sapia S, Sobrinho-Simões M, Eloy C.

Virchows Arch. 2017 May;470(5):517-525. doi: 10.1007/s00428-017-2095-1. Epub 2017 Feb 24.

PMID:
28236059
15.

Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.

Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simões M.

Am J Surg Pathol. 2017 Jun;41(6):854-860. doi: 10.1097/PAS.0000000000000793.

PMID:
28009606
16.

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia).

Sánchez-Ares M, Cameselle-Teijeiro JM, Vázquez-Estévez S, Lázaro-Quintela M, Vázquez-Boquete Á, Afonso-Afonso FJ, Casal-Rubio J, González-Piñeiro AL, Rico-Rodríguez Y, Fírvida-Pérez JL, Ruíz-Bañobre J, Couso E, Santomé L, Pérez-Becerra R, García-Campelo R, Amenedo M, Azpitarte-Raposeiras C, Antúnez J, Abdulkader I.

Oncol Lett. 2016 Aug;12(2):1403-1407. Epub 2016 Jun 28.

17.

ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.

Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M.

Eur J Endocrinol. 2016 Apr;174(4):R117-26. doi: 10.1530/EJE-15-0605. Epub 2015 Oct 28. Review.

PMID:
26510840
18.

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.

Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P.

J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29.

19.

Small cell tumors of the thyroid gland: a review.

Eloy C, Cameselle-Teijeiro JM, Rousseau E, Sobrinho-Simões M.

Int J Surg Pathol. 2014 May;22(3):197-201. doi: 10.1177/1066896913510029. Epub 2013 Nov 25. Review.

PMID:
24275884
20.

High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.

Brea-Fernández AJ, Cameselle-Teijeiro JM, Alenda C, Fernández-Rozadilla C, Cubiella J, Clofent J, Reñé JM, Anido U, Milá M, Balaguer F, Castells A, Castellvi-Bel S, Jover R, Carracedo A, Ruiz-Ponte C.

Clin Genet. 2014 Jun;85(6):583-8. doi: 10.1111/cge.12232. Epub 2013 Jul 28.

PMID:
23837913
21.

Adrenal carcinoma: a retrospective analysis of our series.

Andujar P, Cabezas-Agrícola JM, Cameselle-Teijeiro JM, Barón-Duarte F, Bernabeu I, Casanueva FF.

Endocrinol Nutr. 2013 Nov;60(9):544-6. doi: 10.1016/j.endonu.2012.12.006. Epub 2013 Mar 26. No abstract available.

PMID:
23540614
22.

Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.

Nakazawa T, Celestino R, Machado JC, Cameselle-Teijeiro JM, Vinagre J, Eloy C, Benserai F, Lameche S, Soares P, Sobrinho-Simões M.

Int J Surg Pathol. 2013 Aug;21(4):379-89. doi: 10.1177/1066896912473355. Epub 2013 Jan 24.

PMID:
23349472
23.

mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.

Faustino A, Couto JP, Pópulo H, Rocha AS, Pardal F, Cameselle-Teijeiro JM, Lopes JM, Sobrinho-Simões M, Soares P.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1139-49. doi: 10.1210/jc.2011-2748. Epub 2012 May 1.

PMID:
22549934
24.

[The value of 18FDG-PET for localization of ectopic Cushing's syndrome due to occult bronchial carcinoid].

Prieto-Tenreiro A, Cabezas-Agrícola JM, Argibay S, Cameselle-Teijeiro JM, Casanueva F.

Endocrinol Nutr. 2011 Nov;58(9):497-9. doi: 10.1016/j.endonu.2011.02.015. Epub 2011 Jun 8. Spanish. No abstract available.

PMID:
21641883
25.

[New report of epididymal adenomatoid tumor. Infrequent pathology].

Tato Rodríguez J, Lema Grille J, Cimadevila García A, Abelenda Barca J, Blanco Parra M, Cimadevila Covelo A, Cameselle Teijeiro JM.

Actas Urol Esp. 1997 May;21(5):502-7. Review. Spanish.

PMID:
9412179
26.

[Adenocarcinoma at an ileostomy site after colectomy for ulcerative colitis].

Ferrandez Rivera M, Baltar Boileve J, Cameselle Teijeiro JM, Gil Gil P.

J Chir (Paris). 1990 Aug-Sep;127(8-9):412-5. Review. French.

PMID:
2229216

Supplemental Content

Loading ...
Support Center